NCT01595165

Brief Summary

Transversus abdominis plane (TAP) block has gained popularity for the control of postoperative pain in various surgeries. Three studies showed inconsistent result on pain control after TAP block in laparoscopic cholecystectomy. The TAP technique used in these studies was classic ultrasound guided TAP block. Besides periumbilical incision, sub-xiphoid incision is usually made during laparoscopic cholecystectomy. As typical posterior TAP rarely extend above T8, the investigators undergo subcostal TAP block for this type of surgery. The investigators are going to investigate the effect of subcostal TAP on early postoperative pain after laparoscopic cholecystectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 9, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

July 9, 2012

Status Verified

July 1, 2012

Enrollment Period

5 months

First QC Date

May 7, 2012

Last Update Submit

July 5, 2012

Conditions

Keywords

laparoscopic cholecystectomyultrasoundtransversus abdominis plane block

Outcome Measures

Primary Outcomes (1)

  • Numerical Rating Scale (NRS) 15 min after entering recovery room

    15 min after entering recovery room

Secondary Outcomes (4)

  • Fentanyl consumption at recovery room

    Up to 3 hours until discharge from recovery room

  • Recovery room stay

    Up to 3 hours from entering recovery room to discharge

  • Incidence of postoperative nausea and vomiting (PONV)

    Up to 3 hours during recovery room stay

  • NRS at 4h, 24h, and 48 h after surgery

    4h, 24h, and 48 h after surgery

Study Arms (2)

Control

PLACEBO COMPARATOR

Control group receiving saline instead of ropivacaine

Procedure: Placebo Ultrasound guided subcostal TAP block

TAP

EXPERIMENTAL

TAP group receiving ropivacaine total of 150 mg at TAP under US

Procedure: Ultrasound guided subcostal TAP block

Interventions

Under ultrasound guidance0.375% ropivacaine 10 ml will be injected between rectus abdominis and transverse abdominis and same study solution will be injected at subcostal transversus abdominis plane. This block will be done bilaterally.

TAP

Under ultrasound guidance saline 10 ml will be injected between rectus abdominis and transverse abdominis and same study solution will be injected at subcostal transversus abdominis plane. This block will be done bilaterally.

Control

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-II
  • Age 20-65 patients scheduled elective laparoscopic cholecystectomy

You may not qualify if:

  • Patient refusal
  • Allergy to ropivacaine
  • Coagulopathy
  • Morbid obesity (BMI\>35 kg/m2)
  • Previous abdominal surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sang-Hyun Kim

Bucheon-si, Gyeonggi-do, 420767, South Korea

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Sang-Hyun Kim, M.D., Ph.D.

    Soonchunhyang University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sang-Hyun Kim, M.D., Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

May 7, 2012

First Posted

May 9, 2012

Study Start

July 1, 2012

Primary Completion

December 1, 2012

Study Completion

March 1, 2013

Last Updated

July 9, 2012

Record last verified: 2012-07

Locations